Daily Dose - May 16th, 2025
Daily Dose |
View online
May 16, 2025
Editor’s (re)View: Trump’s executive order on drug pricing could hurt Big Pharma’s reshoring
PhRMA warned that President Trump’s executive order on most favored nation would jeopardize hundreds of billions of dollars in planned U.S. investments by its members.
Read More
Cybin taps Thermo Fisher for US manufacturing support for Phase 3 program
Thermo Fisher Scientific will provide clinical and commercial supply for Cybin’s late-stage major depressive disorder candidate.
Read More
Aldevron, Integrated DNA Technologies tout world’s first mRNA-based personalized CRISPR therapy
The on-demand therapy was manufactured in six months for an infant with a rare, life-threatening metabolic disorder.
Read More